CNIO researchers show that telomeres are linked to the origins of idiopathic pulmonary fibrosis

July 2, 2015
Samples from mouse lungs show collagen fibers that generate pulmonary fibrosis. Credit: CNIO

Idiopathic pulmonary fibrosis (IPF) causes a gradual loss of respiratory capacity and can be lethal within a few years. The cause is unknown, although it can be attributed to a combination of genetics and the environment. A team of researchers from the Spanish National Cancer Research Centre (CNIO) have now discovered that telomeres, the structures that protect the chromosomes, are at the origin of pulmonary fibrosis. This is the first time that telomere damage has been identified as a cause of the disease. This finding opens up new avenues for the development of therapies to treat a disease for which there is currently no treatment.

This work, carried out by Juan M. Povedano and Paula Martínez from the Telomeres and Telomerase Group at CNIO led by Maria A. Blasco, with the participation of researchers from the CNIO Molecular Imaging Core Unit and from the Complutense University of Madrid, is being published this week in the journal Cell Reports.

Idiopathic is a respiratory disease ? affecting about 8,000 people in Spain ? in which scars are formed in lung tissue that make it rigid, leading to breathing difficulties. In the absence of a single and determinant cause, researchers compile clues that piece together different parts of the problem. One is that the exposure to environmental hazards, such as radiation, smoking or pollution, greatly increases the risk.

Other clues already pointed to the . For example, the telomeres of many patients suffering from idiopathic pulmonary fibrosis are shorter than normal. Furthermore, pulmonary fibrosis is one of the most frequent illnesses among people with mutations in genes involved in telomere maintenance. These data suggest that there is an association between telomere defects and the disease, but demonstration of causation was pending.

Telomere Defects

In search of a cause-effect relationship, CNIO researchers created a mouse that lacked a protein needed to build telomeres in a specific cell population—type II alveolar cells—and which is indispensable for lung tissue regeneration.

The results left no room for doubt: most of the animals developed progressive pulmonary fibrosis. The researchers, after finding that the lack of telomeres is lethal for type II alveolar cells, reached the conclusion that lung epithelium cannot regenerate without these cells and, therefore, cannot repair damage caused by toxic environmental agents.

This result demonstrates, for the first time, that telomere damage may cause pulmonary fibrosis. In the words of Martínez: "We have seen that acute telomere damage is sufficient to trigger pulmonary fibrosis, even in the absence of environmental damage."

A Model That Reproduces The Disease In Humans

Although the mouse lacking telomeres in pulmonary epithelial cells proves the importance of telomeres in the origin of fibrosis, it does not however reproduce the disease in most human patients.

In humans, environmental hazards play an important role in the disease. Furthermore, short telomeres are also a feature of the disease. Very short telomeres are a permanent damage to cells and they stop dividing. When this happens, pulmonary tissue will cease to regenerate, and instead, a "protective" programme against damage will be triggered that causes scar formation—which leads to fibrosis.

The researchers therefore developed an animal model that combines premature shortening of the telomeres due to telomerase deficiency, with low doses of . To induce damage they chose bleomycin, a drug that affects the genetic material of cells and inhibits cell division when administered in high doses, but not enough to cause pulmonary fibrosis in normal mice at the low doses administered by the authors.

They saw that there is a synergy between the damage caused by bleomycin at low doses and the one caused by short telomeres. The shortening of the telomeres is not in itself sufficient to generate fibrosis, nor, in general, is bleomycin at low doses; however, both factors together do trigger the disorder.

"These findings support a model in which persistent damage derived from short or dysfunctional telomeres is added to other cellular damage and this triggers pulmonary fibrosis," says Povedano.

The new animal models are essential for testing new "therapeutic strategies based on the activation of telomerase [the enzyme that repairs telomeres]," concludes the paper in Cell Reports.

A Link To Ageing

This new evidence, which focuses on telomeres, fits in well with the fact that idiopathic pulmonary fibrosis only occurs in people over 50 years of age; it is precisely in the telomeres where one of the main molecular symptoms of cellular ageing occurs. Telomeres become shorter each time a cell divides; the older the organism, the greater the number of divisions and the shorter the telomeres.

Blasco asserts: "Understanding the molecular mechanisms that lead to the ageing process, such as the shortening of telomeres, has enabled us to generate animal models that faithfully reproduce diseases such as , and this is already helping us to test novel therapies that we hope will prove effective and that are based on the activation of the enzyme telomerase."

Explore further: Study provides insights on chronic lung disease

More information: Mice with pulmonary fibrosis driven by telomere dysfunction. Juan M. Povedano, Paula Martinez, Juana M. Flores, Francisca Mulero, Maria A. Blasco. Cell Reports (2015). DOI: 10.1016/j.celrep.2015.06.028

Related Stories

Study provides insights on chronic lung disease

June 15, 2015
A new study shows that shorter telomeres—which are the protective caps at the end of a cell's chromosomes—are linked with worse survival in a progressive respiratory disease called idiopathic pulmonary fibrosis (IPF). ...

The CNIO links telomeres to the origins of liver diseases such as chronic hepatitis and cirrhosis

April 16, 2015
Telomeres are DNA regions at the ends of our chromosomes that protect the genetic data of cells, preventing mutations and alterations in the DNA that could potentially cause disease. Telomeres shorten throughout life in a ...

Mutations in two genes linked to familial pulmonary fibrosis and telomere shortening

May 4, 2015
Researchers at UT Southwestern Medical Center have identified mutations in two genes that cause a fatal lung scarring disease known as familial pulmonary fibrosis.

New research finds link between telomere length and lung disease

February 4, 2015
Brigham Young University biologist Jonathan Alder has a startling secret he doesn't freely share: he knows when most of us are going to die.

Mutations linked to repair of chromosome ends may make emphysema more likely in smokers

January 14, 2015
Mutations in a gene that helps repair damaged chromosome ends may make smokers—especially female smokers—more susceptible to emphysema, according to results of a new study led by Johns Hopkins Kimmel Cancer Center researchers.

Recommended for you

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.